WCG
BSX icon

Weaver Consulting Group’s Boston Scientific BSX Stock Holding History

Weaver Consulting Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-131
Closed -$5K – 234
2020
Q3 		$5K Hold
131
– – ﹤0.01% 677
2020
Q2 		$5K Hold
131
– – ﹤0.01% 649
2020
Q1 		$4K Hold
131
– – ﹤0.01% 590
2019
Q4 		$5K Buy
131
+115
+719% +$4.81K ﹤0.01% 595
2019
Q3 		$1K Hold
16
– – ﹤0.01% 766
2019
Q2 		$1K Hold
16
– – ﹤0.01% 755
2019
Q1 		$1K Buy
+16
New +$611 ﹤0.01% 1410

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Weaver Consulting Group's BSX Position: Q4 2020 in Review

Weaver Consulting Group sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 131 shares — an estimated $5K sold.

Weaver Consulting Group first reported a position in BSX in Q1 2019 and held it in 7 quarters. The position peaked at $5K in Q3 2020. 863 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Weaver Consulting Group reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 131 Boston Scientific shares in Q4 2020, an estimated $5K.
  • Weaver Consulting Group first reported a position in Boston Scientific in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Boston Scientific position peaked at $5K in Q3 2020.
  • 863 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.